The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Chugai Pharma; Gilead Sciences; Ipsen; Janssen; Merck; MSD; Novartis; RIEMSER
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Cellax; ClinSol; Hexal; iOMEDICO; MSD; Novartis; RIEMSER; Roche; Tesaro; Teva
 
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Falk Foundation; Lilly; Merck Serono; MSD; Nordic Bioscience; Pfizer; Roche
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); European Organisation for Research and Treatment of Cancer (EORTC) (Inst); Merck Serono (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Serono; MSD; Roche
A randomized, double-blinded, placebo-controlled multicenter phase II trial of adjuvant immunotherapy with tecemotide (L-BLP25) after R0/R1 hepatic colorectal cancer metastasectomy (LICC): Final results.
 
Carl Christoph Schimanski
Employment - Merck KGaA (I)
Research Funding - Merck KGaA (Inst)
 
Stefan Kasper
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Roche; Shire; Shire
Consulting or Advisory Role - Amgen; AstraZeneca; Baxalta; Bristol-Myers Squibb; Lilly; Merck Serono; MSD Oncology; Roche; Sanofi; SERVIER
Research Funding - Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; SERVIER
Travel, Accommodations, Expenses - Amgen; Lilly; Merck Serono; Roche; Sanofi
Other Relationship - Amgen; Merck Serono; Sanofi
 
Susanna Hegewisch-Becker
No Relationships to Disclose
 
Jan Schroeder
No Relationships to Disclose
 
Friedrich Overkamp
No Relationships to Disclose
 
Frank Kullmann
No Relationships to Disclose
 
Wolf Otto Bechstein
Honoraria - Astellas Pharma; Baxter; Integra LifeSciences; Medupdate; Merck Serono; Miami Cancer Institute; Teva
Consulting or Advisory Role - Astellas Pharma
Speakers' Bureau - Integra LifeSciences
 
Matthias Voehringer
Consulting or Advisory Role - Roche
 
Robert Oellinger
No Relationships to Disclose
 
Florian Lordick
Honoraria - AstraZeneca; BioNTech; Bristol-Myers Squibb; Elsevier; Infomedica; Lilly; Merck KGaA; Merck Sharp & Dohme; Roche; SERVIER
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; SERVIER
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly
 
Volker Heinemann
Honoraria - Amgen; Baxalta; Boehringer Ingelheim; Celgene; Lilly; Merck; Roche; Sanofi; SERVIER; Sirtex Medical; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Baxalta; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Halozyme; Merck; MSD; Roche; Sanofi; SERVIER; Sirtex Medical
Research Funding - Amgen (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Merck (Inst); Roche (Inst); Shire (Inst); Sirtex Medical (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; MSD; Roche; SERVIER; Shire; Sirtex Medical
 
Michael Geissler
No Relationships to Disclose
 
Armin Schulz-Abelius
No Relationships to Disclose
 
Bernhard Linz
No Relationships to Disclose
 
Helga Bernhard
No Relationships to Disclose
 
Michael R. Schoen
No Relationships to Disclose
 
Richard Greil
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Merck; MSD; Novartis; Roche; Sandoz; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; Novartis; Roche; Takeda
Research Funding - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Merck; MSD; Novartis; Roche; Sandoz; Takeda
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Janssen; Roche
 
Victoria Smith-Machnow
No Relationships to Disclose
 
Irene Schmidtmann
Research Funding - Merck Serono (Inst)
 
Markus Hermann Moehler
No Relationships to Disclose